peptide drugs approved by fda 31 approved by the United States food and drug administration (FDA - Peptide-drug conjugates liraglutide, semaglutide, and insulin degludec The Expanding Landscape of Peptide Drugs Approved by the FDA

Peptide drugslist The field of peptide therapeutics has witnessed significant growth and innovation, marked by an increasing number of peptide drugs approved by the FDAInformed Consent for GHK-Cu Cream - Superpower. These therapeutic peptides are complex molecules that play crucial roles in various biological processes, making them attractive candidates for drug development. The FDA has been instrumental in bringing these advancements to patients, with a notable rise in the approval of peptide therapeutics in recent yearsTop 10 Anti-Aging Peptides: What They Actually Do.

The journey of a peptide drug from discovery to market is intricate, involving rigorous research, development, and regulatory oversight. The FDA's role is to ensure the safety and efficacy of these novel treatments before they become available to the public.作者：H Zhang·2022·被引用次数：316—Terlipressin and setmelanotideare the only two approved cyclic peptides that were developed from the natural linear hormone by introducing a ... This commitment to patient well-being is reflected in the careful evaluation process for each peptide drug.

Understanding Peptide Drugs: A Closer Look

Peptides are short chains of amino acids, the building blocks of proteins. Their small size and specific structures allow them to interact with biological targets in a highly precise manner, leading to a wide range of therapeutic effects作者：L Wang·2022·被引用次数：2170—Approved peptide drugs, such asliraglutide, semaglutide, and insulin degludec, were conjugated with C14/16/18fatty acids, which increased .... The development of peptide-based drugs has opened new avenues for treating diseases that were previously difficult to manage.Cyclic peptide drugs approved in the last two decades (2001 ...

The number of FDA-approved therapeutic peptides has steadily increased. For instance, between 2016 and 2023, approximately 31 peptide-based drugs received FDA approval. Looking at more recent data, in 2023 alone, various structural peptides were approved, including linear, cyclic, and lipopeptides, solidifying their presence in the pharmaceutical landscape.Current Status of Peptide Medications and the Position ... In 2024, the FDA approved fifty novel drugs, with a portion of these being four peptides and oligonucleotides (TIDEs), further underscoring the growing importance of this class of therapeutics2025年2月5日—FDA-approved peptide drugs, including GLP-1 therapies for diabetes, peptide therapeutics for cancer, and innovations in peptide drug ....

Key Areas of Peptide Drug Application

The applications of FDA-approved peptide drugs are diverse and expanding作者：S Jain·2024·被引用次数：35—The THPdb2 database is an updated version of THPdb andprovides the latest comprehensive information on FDA-approved therapeutic peptidesand proteins. The .... Some of the most prominent areas include:

* Diabetes Management: GLP-1 therapies have revolutionized diabetes treatment. Drugs like liraglutide and semaglutide, which have been conjugated with fatty acids to improve their pharmacokinetic profiles, are prime examples of successful peptide therapeutics.

* Oncology: Peptide-based therapies are showing promise in the fight against cancer. For example, Vorinostat (Voranigo) is one of the first-in-class therapies approved in 20242021年5月19日—This guidance is intended to assist potential applicants in determining when an application for a syntheticpeptide drugproduct (synthetic ....

* Rare Diseases: Trofinetide (DaybueTM) is a recent example of an FDA-approved peptide drug for a specific rare disease.

* Infectious Diseases: Rezafungin (RezzayoTM), a cyclic peptide, was approved in 2023 for the treatment of candidemia, highlighting the versatility of cyclic peptide drugs.

* Cardiovascular Health: While not always directly approved as peptide drugs themselves, some historical venom-based peptide therapeutics like captopril have paved the way for understanding peptide mechanisms作者：EM Jülke·2025·被引用次数：7—From 2017–2022, the U.S. Food and Drug Administration (FDA) has approvedten macrocyclic peptide therapeuticswith ring sizes ranging from six to 17 amino ....

Advancements in Peptide Drug Development

The field is not only seeing an increase in approvals but also significant advancements in peptide-based drug development. This includes innovations in peptide-based drug delivery systems, aiming to improve oral bioavailability and reduce administration frequency...FDA-approved therapeutic peptidesare administered via 3 different routes: intravenous, oral, and subcutaneous. As indicated in Table 1, intravenous .... The development of peptide-drug conjugates is another exciting area, combining the specificity of peptides with the potency of other therapeutic agents.

The FDA's guidance for industry on synthetic peptides and ANDAs for certain highly purified synthetic peptide drug products demonstrates the regulatory body's commitment to facilitating the development and approval of these complex molecules. This guidance helps applicants navigate the regulatory pathways for synthetic peptide drug products... 1 More than 100 peptide therapeutics are currently available, with31 approved by the United States food and drug administration (FDA) between 2016 and 2023 ....

Notable Peptide Drugs and Their Significance

The landscape of FDA-approved peptide drugs includes a growing list of significant compounds. Some of the top innovator drugs, based on the number of approvals, include oxytocin, semaglutide, teriparatide, and exenatide.Compounded drugs containing semax (heptapeptide) may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and ... On the generic side, octreotide has seen numerous approvals.作者：O Al Musaimi·2018·被引用次数：69—2017 was an excellent year for peptides, with the FDA approvingfive peptides and one peptidomimetic, which together accounted for 13% of the drugs accepted ...

Historically, Tesamorelin is an example of an FDA approved drug for a specific indication, HIV lipodystrophy.2022年1月25日—Thymus hormone, Thymalfasin, 28aa, SciClone Pharms International ; Thymus hormone · Thymopentin, 5aa, Recordari, Italofarmaco, Johnson & Johnson. The development of cyclic peptides has also been a significant area of research, with drugs like Terlipressin and setmelanotide being notable examples of approved cyclic peptides.

Databases such as THPdb and its updated version, THPdb2, play a crucial role in compiling and providing comprehensive information on FDA-approved therapeutic peptides and proteins. These resources are invaluable for researchers and clinicians seeking detailed insights into the available peptide therapies.

The Future of Peptide Therapeutics

The trajectory of peptide drugs approved by the FDA indicates a bright future for this class of therapeutics作者：EM Jülke·2025·被引用次数：7—From 2017–2022, the U.S. Food and Drug Administration (FDA) has approvedten macrocyclic peptide therapeuticswith ring sizes ranging from six to 17 amino .... The ongoing research into novel peptide structures, delivery methods, and therapeutic applications suggests that we will continue to see a steady stream of FDA-approved peptide drugs addressing unmet medical needs. The peptide revolution in medicine is well underway, offering hope and improved treatment options for patients worldwide. The increasing number of drugs in development and the continuous breakthroughs in understanding peptides point towards a sustained period of innovation in this vital area of healthcare.